An Evaluation of Levalbuterol HFA in the Prevention of Exercise-Induced Bronchospasm

BACKGROUND: Exercise-induced bronchospasm (EIB) affects up to 90% of all patients with asthma. OBJECTIVE: This study evaluated the ability of levalbuterol hydrofluoroalkane (HFA) 90 μg (two actuations of 45 μg) administered via metered dose inhaler (MDI) to protect against EIB in mild-to-moderate as...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearlman, D.S., Rees, William, Schaefer, Kendyl, Huang, Holly, Andrews, William T.
Formato: Texto
Lenguaje:English
Publicado: Informa Healthcare 2007
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409177/
https://www.ncbi.nlm.nih.gov/pubmed/17994402
http://dx.doi.org/10.1080/02770900701595667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409177/
https://www.ncbi.nlm.nih.gov/pubmed/17994402
http://dx.doi.org/10.1080/02770900701595667

Ejemplares similares